Check out our new @PLOSGPH paper exploring the impact and cost-effectiveness of near point-of-care technology for diagnosing #tuberculosis in children in primary healthcare settings. Read it here: doi.org/10.1371/jour... From @petedodd24.bsky.social

📢 In our PREPRINT with @petedodd24.bsky.social‬ - medrxiv.org/cgi/content/... we estimate that ~340K women developed #tuberculosis during pregnancy & postpartum globally in 2023. Critical insights for maternal health.

WHO recommends treatment decision scoring algorithms to help diagnose child #Tuberculosis. Thx to #Unitaid, our TB-Speed team evaluated them to be very cost-effective for children with severe acute malnutrition in UGA & ZAM www.sciencedirect.com/science/arti...

Meeting the health needs of incarcerated people can be costly. We found that targeted #tuberculosis infection screening at 1st reception in England could be cost saving. www.sciencedirect.com/science/arti...